PRAX FY 2020 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$6B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$62M

Net Income

-$62M

EPS (Diluted)

$-103.61

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$303M

Total Liabilities

$16M

Stockholders' Equity

$287M

Cash & Equivalents

$297M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$679,000	+100.0%
Operating Income	-$62M	-$36M	-73.1%
Net Income	-$62M	-$36M	-74.1%